DNA Origami Market Size, Share, and Analysis, By Product Type (Products {Kits, Scaffolds, Strands, and Others}, and Services), By Application (Drug Delivery, Biosensors, Therapy, and Others), By End-user (Contract Research Organizations (CROs), Academic & Research Organizations, Pharmaceutical & Biotechnology Companies, and Others), and Regional Forecast, 2024-2032

DNA origami is a nanoscale technique that involves the folding of long strands of DNA into complex, two- and three-dimensional shapes. This is achieved by using short, complementary DNA strands called the "staple strands" to bind to a long, single-stranded DNA "scaffold" in a precise manner. The specificity of the DNA base pairing allows for the self-assembly of these structures with high precision and programmability. DNA origami has numerous applications, including drug delivery systems, nanoscale devices, and biomedical engineering. It can be used to create structures that mimic biological systems, such as viruses, and can be functionalized with various molecules for specific purposes. The process of designing and fabricating DNA origami structures relies on the natural tendency of complementary DNA strands to bind together through hydrogen bonds, enabling the self-assembly of complex nanoscale architectures.

The market growth is primarily attributed to the rising use of this technique in versatile applications such as drug delivery, nanophotonics, nanoelectronics, biosensing, and molecular robotics. Moreover, there are continuous advancements in the design, synthesis, and assembly techniques for DNA origami, including the development of new computational tools and automation. This is expected to increase the complexity, scalability, and efficiency in the fabrication of DNA origami structures, driving market growth during the forecast period.   

• For instance, as per the article published by Stellarix.com in March 2023, DNA origami technique has several therapeutic and non-therapeutic domains, including delivery (drugs, proteins, enzymes, antibodies, and nucleic acids), studies (biomolecule, light, energy, and microscopy), therapy (gene therapy, chemotherapy, immunotherapy, and phototherapy), nanotechnology (nanofabrication, nanophotonics, nanoelectronics, and nano-robots), and many more.

Furthermore, the growing prevalence of various diseases, such as cancers, is driving the need for advanced drug delivery systems, which is expected to boost the demand for DNA origami techniques, thereby strengthening the market growth in the coming years. In addition, the increasing use of DNA origami in targeted therapies to reduce drug side effects is another factor contributing to the market growth in the forthcoming years.

The COVID-19 pandemic had a significant impact on the DNA origami market in 2020. The demand for DNA origami techniques increased during the COVID-19 pandemic, driven by its potential applications in developing effective vaccines and therapeutics, as well as the continued investments by life sciences companies despite some initial operational challenges. The pandemic itself highlighted the need for rapid and efficient vaccine development platforms such as DNA origami nanoparticles.

Segmentation

Key Insights

The report covers the following key insights:

• Incidence of Key Diseases, By Key Countries/Region, 2023


• Technological Advancements in the DNA Origami Market


• Overview: Applications of DNA Origami


• Key Industry Developments By Key Players


• Impact of COVID-19 on the Market

Analysis by Application

On the basis of application, the market is segregated into drug delivery, biosensors, therapy, and others. The drug delivery segment is anticipated to account for a significant share of the global DNA origami market during the forecast period. In recent times, there has been an increased demand for efficient drug delivery systems that can augment the performances and precision of the drugs administered to the patients. The improvement in the precision and the performance of these drugs can lead to improved patient outcomes. Hence, the techniques of DNA origami are being increasingly used for the development of technologically superior drug delivery systems. Some of the advantages associated with the utilization of DNA origami techniques for the development of improved drug delivery systems include the inherent properties of DNA, such as their spatial addressability and biocompatibility.

• For instance, as per the research study published by the journal Advanced Materials in September 2023, DNA origami techniques have shown an increased potential in terms of development as advanced drug delivery systems for novel drugs applicable to a wide range of diseases.

On the other hand, the therapy segment is anticipated to grow at a substantial CAGR during the forecast period. In the current scenario, there has been an increased emphasis on the research & development initiatives involving the utilization of DNA Origami for the administration of various therapies, including cancer therapies.

Regional Analysis

To gain extensive insights into the market, Request for Customization

The global market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to hold a significant share of the DNA origami market during the forecast period. The market growth is primarily attributed to the rising research and development activities in the region that involve the use of DNA origami techniques. For instance, as per the article published by OPTICA in August 2023, researchers at the Massachusetts Institute of Technology (MIT) in the U.S. developed a faster way to create 2D arrays of quantum rods using DNA origami technology. This technique could be incorporated into micro-LEDs for televisions or virtual reality devices. Such developments are expected to boost the adoption of DNA origami technique, driving the regional market growth in the coming years.

Asia Pacific is projected to grow significantly during the forecast timeframe. The key countries in the region, such as China, Japan, and India, have been investing heavily in the building of advanced healthcare infrastructure and attracting major DNA origami companies to establish operations in the region. Such availability of cutting-edge facilities and the greater involvement of industry leaders are further stimulating the demand for DNA origami technologies in the region, which is expected to boost market growth during the forecast period.

Key Players Covered

The market consists of significant players such as Tilibit Nanosystems, DNA Nanobots, LLC, GATTAquant GmbH, and Nanogami.

Key Industry Developments

• In May 2024, in a study published in the Journal of the American Chemical Society, a team of researchers from the universities of Leicester and Portsmouth in the U.K. demonstrated a novel method for the strengthening and customization of DNA origami. This process is called triplex-directed photo-cross-linking and reduces the DNA origami’s sensitivity to heat and potential disassembly through enzymatic action.


• In January 2024, DNA Nanobots, LLC, a U.S.-based company holding a licensed product portfolio of DNA nanostructures (DNA origami), announced the closure of a pre-seed investment funding round.


• In January 2024, in a study published in Nature Communications, researchers from the Karolinska Institutet in Sweden utilized DNA origami to demonstrate the activation of the Notch cell receptor in a previously known technique. The study also demonstrated that the Notch cell receptor can be activated on demand with the aid of a protein called Jag1.